Transcript Document
Change in average Birmingham Vasculitis Activity Score (BVAS) with MMF treatment End point Baseline 24 wk 52 wk Mean BVAS 9.1 2.81.9* 2.84.3** *p=0.0013, **p=0.0044 vs baseline Joy S et al. Nephrol Dial Transplant 2005; 20: 2725-2732. MMF may offer less toxic treatment for ANCA-smallvessel vasculitis [Rheumawire > News; Dec 20, 2005]